Archive for the ‘Gene Therapy Research’ Category

Kate Young, RN-ACNP, Genetics Counselor
Kate Young has worked with CHRISTUS Schumpert #39;s Cancer Treatment Center team for nearly 20 years. She is certified in advanced oncology and is a genetic educator. Young is an alumna of the City of Hope intensive course in cancer risk assessment.

By: CHRISTUSHealthSB

See more here:
Kate Young, RN-ACNP, Genetics Counselor - Video

1 Crazy Trick To Build Muscle
1 crazy trick to build muscle: monstermassbuilding.com Hey man, Are you tired of being skinny? Do you want to get a ripped, muscular body...FAST? Well if you do, then you found the right video! Because in this video I #39;m going to show you how my friend Johnson went from a skinny, weak 140 lbs...to being ripped and muscular at 190 lbs. The way that he made this transformation was by using 1 CRAZY muscle building trick in his workouts. I just posted a new video that shows how this trick works, and how YOU can use it to build the muscular body you #39;ve always wanted. You can watch the video at monstermassbuilding.com If you #39;re a normal guy who #39;s ready to finally build muscle, check out that video now to learn the trick. I have to warn you though -- although this #39;trick #39; helps you build muscle without spending any additional time in the gym, it DOES make your workouts way more intense. So if you #39;re a little girly-man who doesn #39;t have what it takes for extreme muscle building workouts, you should NOT watch that video. Not only will I show you the "trick" that Johnson used to build muscle in that video, I #39;ll also show you... ** The 3 BIGGEST mistakes guys make when building muscle -- which YOU may be making right now! I #39;ll show you exactly what each mistake is, and what to do instead to build the muscular body you want. ** How to gain muscle even if you #39;re genetically skinny and it #39;s putting on size is difficult for you. If you #39;re a skinny guy, I #39;ll show you what you have to do ...

By: sixpackshortcuts

Read the original post:
1 Crazy Trick To Build Muscle - Video

Prenatal and Postpartum Disorders
In this Video Dr. Steinberg speaks about prenatal and postpartum disorders and discusses the impact of both genetics and human relationships on the likelihood and consequences of such disorders. Dr. Carolyn Steinberg MSC,MD, FRCPC Clinical Associate Professor UBC Medical Leader Infant Child Adolescent Psychiatry Richmond Hospital, Dept of Psychiatry Richmond Early Childhood Mental Health Program

By: KidCareCanada

Go here to see the original:
Prenatal and Postpartum Disorders - Video

Karras Farm - Awassi Fat Tail Dairy Sheep at 9mo Old
Here is a look at our Awassi fat tail sheep at nine months old. Karras Farm is the only provider of full blood Awassi dairy sheep in the United States at this time. Our imported Awassi embryos into the United States have provided new dairy sheep genetics to the USA. Thanks you for watching the video and please contact Karras Farm with any questions. Andy Karras karrasfarm.com http eastfriesiansheep.com

By: KarrasFarm

See the article here:
Karras Farm - Awassi Fat Tail Dairy Sheep at 9mo Old - Video

Savage Genetics -- Silent Hill (BroStep Remix)
Remix- #1099; #1085; #1072; #1089; #1072; #1091; #1085; #1076; #1090; #1088; #1077; #1082; #1080; #1080; #1079; #1082; #1086; #1084; #1087; #1100; #1102; #1090; #1077; #1088; #1085; #1086; #1081; #1080; #1075; #1088; #1099; Silent Hill. #1048; #1085; #1092; #1086; #1088; #1084; #1072; #1094; #1080; #1103; #1086; #1073; Silint Hill: http://www.konami.com #1053; #1072; #1096; #1072; #1075; #1088; #1091; #1087; #1087; #1072; #1074; #1042; #1050;:vk.com

By: BroStepRussia

Continue reading here:
Savage Genetics -- Silent Hill (BroStep Remix) - Video

Star Adairis Structures.
The sound effects are from StarCraft, and belong to Blizzard. Names: VISERAK: Citadel Castellum Dynamo Electron Slinger Foundry Harbor Maintanance Bay Propulsion Lab Recon Terminal Rift Anchor Seismic Synthesizer Sphere Purifier Stasis Chamber Warp Relay Support Facility Temple of Hemsway KANDLIA: Blood Mound Combustion Chamber Cruor #39;s Nest Draliskan Nest GigaDraliskan Cave Flyer #39;s Tower Flyer #39;s Column Food Sac Genetics Gland DemiHive Hive Clutch Sulfra Jolt Orb Digestor Spline SAPPHIRIAN: Proton Battery Armor Facility Armor Forge Pulsar Cannon Capitol General #39;s Hall Infantry Division Marble Incinerator Praetorian Fortress Star Core StarBase Tech Center ANTARCTOSPHERE Command Base Command Bridge Command Central Core Refinery Flak Cannon Kaiser #39;s Quarters Munitions Bay Orbital Station Perimeter Platform Shockwave Cannon SkyTech Labs Space Command Uplink Star Carrier Tech Assembly Supply Unit System Supply Troop Center

By: Kaiser StratosTygo

Originally posted here:
Star Adairis Structures. - Video

SEATTLE, WA--(Marketwire - Jan 7, 2013) - Atossa Genetics, Inc. ( NASDAQ : ATOS ), The Breast Health Company, announced today that Kyle Guse, 49, has joined the Company as Chief Financial Officer, General Counsel and Secretary. Mr. Guse brings more than 20 years of experience advising companies on public offerings, private financing, mergers and acquisitions, commercialization transactions and other corporate matters. He has completed in excess of 100 financings and other transactions totaling more than $1 billion with many life sciences and other innovative and fast growing companies.

Mr. Guse is a licensed Certified Public Accountant and lawyer.During the past year, he practiced law as a partner in the Silicon Valley office of Baker Botts LLP. From 2007 to 2012, he was a partner at McDermott Will & Emery LLP. From 1995 to 2007, Mr. Guse practiced law at Heller Ehrman LLP. He began his career in 1987 at Deloitte & Touche. Mr. Guse holds a BS in Business Administration and MBA from California State University, Sacramento, and a Juris Doctorate from Santa Clara University School of Law.

Dr. Steven C. Quay, Chairman, CEO and President, stated, "Kyle Guse is joining Atossa at a pivotal time as we accelerate the national roll-out of our ForeCYTE and ArgusCYTE Breast Health Tests and complete the development of additional tests and services. We are thrilled to have someone with Mr. Guse's financial and legal experience join us as we roll out our patented, FDA-cleared breast health products and services across the U.S."

Dr. Quay continued, "I would like to thank Chris Benjamin for his service as our interim Chief Financial Officer, including his assistance in successfully bringing us through the IPO process."

"This is a very exciting opportunity to join an emerging molecular diagnostics company focused exclusively on breast health that has developed and is selling innovative products and services," commented Mr. Guse. "I look forward to working with the Atossa team and the Board of Directors on financial strategy and execution so that Atossa can continue to commercialize its unique portfolio of products and services."

On January 4, 2013, Mr. Guse was awarded options to purchase a total of 500,000 shares of common stock of the Company, par value $0.001 per share, 95,000 of which were granted under the Company's 2010 Stock Option and Incentive Plan and 405,000 of which were granted outside the plan. The stock options have an exercise price equal to $4.11 per share, the fair market value on the grant date and vest over a four-year period with 25% vesting on his first anniversary and quarterly thereafter. The stock options were granted as an inducement to Mr. Guse's entering into employment with the Company.

For more information, please click the following link to view a video interview with Dr. Quay discussing aspects of this press release in more detail: http://client.irwebkit.com/AtossaGenetics/media. You may also sign up to receive automatic email News Alert updates there.

About Atossa Genetics, Inc.

Atossa Genetics, Inc. ( NASDAQ : ATOS ), The Breast Health Company, is based in Seattle, WA, and is focused on preventing breast cancer through the commercialization of patented, FDA-cleared diagnostic medical devices and patented, laboratory developed tests (LDT) that can detect precursors to breast cancer up to eight years before mammography, and through research and development that will permit it to commercialize treatments for pre-cancerous lesions.

The National Reference Laboratory for Breast Health (NRLBH), a wholly owned subsidiary of Atossa Genetics, Inc., is a CLIA-certified high-complexity molecular diagnostic laboratory located in Seattle, WA, that provides the patented ForeCYTE Breast Health Test, a risk assessment test for women 18 to 73 years of age akin to the Pap Smear, and the ArgusCYTE Breast Health Test, a blood test for recurrence in breast cancer survivors that provides a "liquid biopsy" for circulating cancer cells and a tailored treatment plan for patients and their caregivers.

View original post here:
Atossa Genetics Names Kyle Guse as Chief Financial Officer, General Counsel and Secretary

Bharat Book Presents: Antiviral Therapeutics - Technologies, Markets and Companies
For more information kindly visit on: http://www.bharatbook.com Summary This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical classification of viral diseases according to their commercial importance. Various antiviral approaches are described including pharmaceuticals and molecular biological therapies such as gene therapy and RNA interference (RNAi) as well as vaccines for virus infections. Expert opinion is given about the current problems and needs in antiviral therapy. SWOT (strengths, weaknesses, opportunities and threats) analysis of antiviral approaches is presented against the background of concept of an ideal antiviral agent. A novel feature of this report is the use of nanotechnology in virology and its potential for antiviral therapeutics. Interaction of nanoparticles with viruses are described. NanoViricides are polymeric micelles, which act as nanomedicines to destroy viruses. Various methods for local as well as systemic delivery of antiviral agents and vaccines are described. Nanobiotechnology plays an important role in improving delivery of antivirals. Advantages and limitations of delivery of gene-based, antisense and RNAi antiviral therapeutics are discussed. Anti-influenza measures applicable to human as well as avian forms are described including the recent epidemic of swine flu. Resistance can develop against ...

By: Deepa Kamath

Link:
Bharat Book Presents: Antiviral Therapeutics - Technologies, Markets and Companies - Video

Stem Cell Therapy for Autism, Mumbai, India

By: Rajeev Ranjan

Read the rest here:
Stem Cell Therapy for Autism, Mumbai, India - Video

By Janice Wood Associate News Editor Reviewed by John M. Grohol, Psy.D. on January 6, 2013

Some brain changesfound in adults with common gene variants linked to disorders such as Alzheimers disease, schizophrenia, and autism can also be seen in the brain scans of newborns, according to new research.

These results suggest that prenatal brain development may be a very important influence on psychiatric risk later in life, said Rebecca C. Knickmeyer, Ph.D., lead author of the study and assistant professor ofpsychiatryat the University of North Carolina School of Medicine.

For the study, 272 infants received MRI scans shortly after birth. The DNA of each was tested for 10 common variations in seven genes that have been linked to brain structure in adults.

These genes have also been implicated in schizophrenia, bipolar disorder, autism, Alzheimers disease, anxiety disorders and depression.

For some polymorphisms, such as a variation in the APOE gene associated with Alzheimers disease, the brain changes in infants looked very similar to brain changes found in adults with the same variants, according to Knickmeyer.

This could stimulate an exciting new line of research focused on preventing onset of illness through very early intervention in at-risk individuals, she said.

But this was not true for every polymorphism included in the study, noted John H. Gilmore, M.D., senior author of the study and vice chair for research and scientific affairs in the UNC Department of Psychiatry.

For example, the study included two variants in the DISC1 gene. For one of these, known as rs821616, the infant brains looked very similar to the brains of adults. But there was no similarity between infant brains and adult brains for the other variant, rs6675281.

This suggests that the brain changes associated with this gene variant arent present at birth, but develop later in life, perhaps during puberty, Gilmore said.

Read the rest here:
Gene Variants Linked to Alzheimer’s, Mental Illness Also Seen in Newborns

Should We Create Children Without Fathers?
In a few years, having a child without a biological father may be possible for any woman who wants to go that route thanks to genetic engineering / stem cell research.

By: videoScribble

Read more from the original source:
Should We Create Children Without Fathers? - Video

Sweet tooths #1 bigbudz genetics
Sweet tooths 18 week old we have messed with the genetics and turns the seeds from auto outdoor 8 week grow to a 22 week grow perfect for cfls seeds will be feminised sweet tooth #1 available online

By: TheMrbigbudz87

See the rest here:
Sweet tooths #1 bigbudz genetics - Video

I #39;m My Own Grandpa - Complete Pedigree
I #39;m My Own Grandpa written by Dwight Latham and Moe Jaffe, with a Complete Pedigree. Who said Genetics is not fun...

By: rivilox

Original post:
I'm My Own Grandpa - Complete Pedigree - Video

Dennis Drayna and the discoveries in the genetics of stuttering
Whilst I was collating information on Drayna I uncovered many pubmed publications of his research. There is a considerable number of titles including: A role for inherited metabolic deficits in persistent developmental stuttering. (Kang C, Drayna D. Mol Genet Metab. 2012 Jul 28.) Studies in a consanguineous family reveal a novel locus for stuttering on chromosome 16q. (Raza MH, Amjad R, Riazuddin S, Drayna D. Hum Genet. 2012 Feb) Analysis of mannose 6-phosphate uncovering enzyme mutations associated with persistent stuttering. (Lee WS, Kang C, Drayna D, Kornfeld S. J Biol Chem. 2011 Nov) Evaluation of the association between polymorphisms at the DRD2 locus and stuttering. (Kang C, Domingues BS, Sainz E, Domingues CE, Drayna D, Moretti-Ferreira D. J Hum Genet. 2011 Jun) Characterization of a mutation commonly associated with persistent stuttering: evidence for a founder mutation. (Fedyna A, Drayna D, Kang C. J Hum Genet. 2011 Jan) Genomewide significant linkage to stuttering on chromosome 12. (Riaz N, Steinberg S, Ahmad J, Pluzhnikov A, Riazuddin S, Cox NJ, Drayna D. Am J Hum Genet. 2005 Apr) A model system for identifying genes underlying complex traits. Drayna D, Kim UK, Coon H, Jorgenson E, Risch N, Leppert M. Cold Spring Harb Symp Quant Biol. 2003 Results of a genome-wide linkage scan for stuttering. Shugart YY, Mundorff J, Kilshaw J, Doheny K, Doan B, Wanyee J, Green ED, Drayna D. Am J Med Genet A. 2004 Jan Link to pubmed: http://www.ncbi.nlm.nih.gov

By: lololcopter123

See the original post:
Dennis Drayna and the discoveries in the genetics of stuttering - Video

Tom Wagner talks about True Potato Seed TPS
Tom Wagner on Growing and Saving True Potato Seeds (TPS). In this video Tom presents a lot of general and interesting information on potato plant genetics, as well as seed saving and cleaning techniques.Tom explains how he uses Tri-Sodium Phosphate to clean his seeds.

By: Tom Wagner

Read more:
Tom Wagner talks about True Potato Seed TPS - Video

Ufo Object In 1400c Jesus Painting By Paolo Uccello Identifed By Gerone Wright
The Ufo object within the 1400c Paolo Uccello painting is a Encrypted symbolization utilized by Uccello to demonstrate the genetic becoming of mankind and thier continued genetic bridging by a select few privied with the knowledge to practice the cult like ritual. Know that I have highlighted a few of the creatures which are responcible for genetics which ultimately lead to our current existences you google the image for yourself and realize that I #39;m on point with my findings. As expressed in the video I can through my genuine paranormal experience/encounter take you within my discoveries to any place in space and allow you to see and experience all that I can and experience, which is everything past, present, and furure. Gerone Wright

By: Geroneification

See the original post:
Ufo Object In 1400c Jesus Painting By Paolo Uccello Identifed By Gerone Wright - Video

Topping Cannabis Plants - LA Confidential / ICE
LA Confidential (DNA Genetics) - 24 days above soil ICE (Royal Queen Seeds) - 25 days above soil (#2) Container Size Put "Great White" Mycorrhiza in hole during germination Grow Lab GL60 Tent 2 #39;x2 #39;x5 #39;3" Hydrofarm T5 4 bulb Roots Organics Soil http://www.advancedledlights.com Filmed with Sony HDR-CX190 LEGAL GROW

By: BombyCron42

Read more from the original source:
Topping Cannabis Plants - LA Confidential / ICE - Video

Dr. Kristy Chandler
Dr. Kristina Chandler, originally from Snellville, Georgia, graduated from the University of Georgia in 2007 with dual Bachelor of Science degrees in Biology and Genetics. She then attended the Medical College of Georgia #39;s School of Dentistry where she earned her DMD degree in 2011. While in dental school, Dr. Chandler participated in Oral Surgery and Pediatric externships at the Floyd County Public Health Department in Rome, Georgia as well as a comprehensive dentistry externship at the Ben Massell Dental Clinic in Atlanta. Throughout her four years of dental school, Dr. Chandler was honored with the Omicron Kappa Upsilon Academic Achievement Award recognizing the top 20% of the class. She was also awarded the Emile T. Fisher Foundation Scholarship, the Simon Eisenberg Scholarship, the Affinity Bank Award, and the International Congress of Oral Implantologists Pre-Doctoral Achievement Award. In addition to her academic achievements, Dr. Chandler enjoyed volunteering with the Georgia War Veterans "Dentists for Della" Project and participating in the Medical Campus Outreach Weekly Women #39;s Bible Study. Dr. Chandler is an active member of the American Dental Association, the Georgia Dental Association, and the Academy of General Dentistry. She is committed to providing the best dental care possible to her patients and continues to advance her skills by actively pursuing her continuing education. When not creating beautiful smiles, Dr. Chandler enjoys traveling, exercising ...

By: Frank Nia

Read more here:
Dr. Kristy Chandler - Video

Atossa Genetics: a focused pure play breast health testing company with huge potential to grow

By Grant Zeng, CFA

Atossa Genetics (NasdaqCM: ATOS ) is a medical diagnostics company focused on the prevention of breast cancer through the development and commercialization of diagnostic tests that can detect precursors to breast cancer , and through the research, development, and ultimate commercialization of treatments for pre-cancerous lesions.

To download a free copy of the full ATOS initiation report, please click here.

Atossa's diagnostic tests consist of patented medical devices cleared by the FDA that can collect fluid samples from the breast milk ducts (nipple aspirate fluid, NAF), where over 85% of breast cancers arise. These samples are processed at the Company's wholly-owned National Reference Laboratory for Breast Health , which has been certified pursuant to the Clinical Laboratory Improvement Amendments (CLIA), has been licensed in the states of California, Florida, Maryland, Rhode Island, and Washington, and is in the process of obtaining a license to accept testing samples from New York. CLIA certification is legally required to receive reimbursement from federal or state medical benefit programs, like Medicare and Medicaid, and is a practical requirement for most third-party insurance benefit programs.

Atossa's CLIA-certified laboratory examines the specimens by microscopy for the presence of normal, pre-malignant, or malignant changes as determined by cytopathology and biomarkers that distinguish "usual" ductal hyperplasia, a benign condition, from atypical ductal hyperplasia (ADH), which may lead to cancer. These cytopathological results provide patients and physicians with information about the care path that should be followed, depending on the individual risk of future cancer as determined by the results.

Additionally, Atossa is conducting research on the treatment of these pre-cancerous cells by using its patented and FDA-cleared microcatheters to deliver, directly into the milk ducts, pharmaceutical formulations that can be used to treat these pre-cancerous lesions. By using this localized delivery method, patients receive high local concentrations of these drugs at the site of the pre-cancerous lesions, potentially promoting efficacy of the treatment while limiting systemic exposure, which has the potential to lower the overall toxicity of these treatments.

Atossa is currently marketing two diagnostic tests and plans to offer two additional tests in early 2013.

Go here to see the original:
Atossa Genetics: a focused pure play breast health testing company with huge potential to grow - Analyst Blog

Source:
http://humanbiologyblog.blogspot.com/2013/01/bone-deposition-in-adolescent-women-who.html

In 2009 a study from Canada reported that slightly overweight people actually were at less risk of dying than people of normal weight (see this blog, July 9, 2009). That study generated a lot of controversy, understandably. One criticism was that the study included “only” 11,000 people, all of whom were Canadians; perhaps the results would not be not be generalizable to other populations.

Now a subsequent much larger study proves the Canadian study right. The most recent study is a meta-analysis of 97 separate studies of weight versus mortality that includes over 2.9 million people. The results show quite convincingly that people who were “overweight” by current government definitions (a Body Mass Index of 25-29.9) were 6 percent less likely to die over a given time period than persons of “normal” weight (BMI 18.5-24.9).

No one is suggesting that people should gain weight just to live longer. For one thing, mortality risk goes up dramatically for persons who are severely or morbidly obese. But the data do call into question the proper definition of “normal” or ideal weight. Perhaps the definitions of normal weight, overweight, and obesity need to be shifted ever-so-slightly to the right, towards slightly higher BMIs.

We may never have a true definition of “ideal” weight, because any such definition would probably have to take into account a whole host of other factors such as physical health and even happiness. But the current data does give one food for thought when it comes to understanding the meaning and value of government definitions of ideal weights.Source:
http://humanbiologyblog.blogspot.com/2013/01/in-2009-study-from-canada-reported-that.html

January 4, 2013

Connie K. Ho for redOrbit.com Your Universe Online

A study by brain researchers at the University of California, Irvine (UCI) recently found that a dopamine-receptor gene variant that is related to personality traits can also impact healthy aging. Their findings were published in the January 2 edition of The Journal of Neuroscience.

In the paper, the researchers described how the gene variant, known as DRD4 7R allele, is associated with both active personality traits and longer life expectancy. The experiment was completed by Robert Moyzis, a professor of biological chemistry at UCI, and Dr. Nora Volkow, a psychiatrist who manages the National Institute on Drug Abuse (NIDA) as well as conducts research at the Brookhaven National Laboratory (BNL).

The scientists used information from the so-called 90+Study, a project affiliated with UCIs Institute for Memory Impairments and Neurological Disorders.

While the genetic variant may not directly influence longevity, explained Moyzis in a prepared statement, it is associated with personality traits that have been shown to be important for living a longer, healthier life. Its been well documented that the more youre involved with social and physical activities, the more likely youll live longer. It could be as simple as that.

The DRD4 7R variant is a part of the dopamine system in the midbrain, a cluster of cells in the brain that assists in the exchange of signals between neurons. The dopamine system is also critical for attention as well as learning reward-driven behaviors.

The DRD4 7R allele causes a weakening of the dopamine signaling system, which in turn results in a greater reactivity of an individual to his or her environment. Moyzis and his team found that the genetic variant was present in significantly higher rates in people over the age of 90, and separate studies have independently corroborated these results by demonstrating that DRD4 7R is related to higher life expectancy in lab mice.

Researchers also believe that people who have this variant gene appear to be interested in activities that are socially, intellectually and physically stimulating. Past studies have found that both physical and mental activity is important for healthy aging, and could help limit neurodegenerative illnesses such as Alzheimers disease. However, attention-deficit/hyperactivity disorders along with addictive and risk-prone behaviors have also been connected to the variant.

For the recent study, the research team looked at genetic samples from 310 participants in the 90+ study. The studys oldest participants showed a 66 percent increase in the number of people carrying the variant gene over the younger control group of 2,902 individuals ranging from seven to 45 years of age. They discovered that the variant was more likely to be present in people who spent a greater amount of time engaging in physical activity.

Here is the original post:
Dopamine Receptor Gene Variant Linked To Longevity And Healthy Ageing

By Rick Nauert PhD Senior News Editor Reviewed by John M. Grohol, Psy.D. on January 4, 2013

New research suggests a genetic variant that accompanies active personality traits in humans also appears to be associated with living a longer life.

In a series of mouse studies, UC Irvine researchers and others discovered that an offshoot of a dopamine-receptor gene called the DRD4 7R allele appears in significantly higher rates in people more than 90 years old and is linked to life-span increases in mouse studies.

Robert Moyzis, Ph.D., professor of biological chemistry at UC Irvine, andNora Volkow, M.D., a psychiatrist who conducts research at the Brookhaven National Laboratory, led the research effort. Findings are online in The Journal of Neuroscience.

Researchers say the variant gene is part of the dopamine system, a network which facilitates the transmission of signals among neurons and plays a major role in the brain network responsible for attention and reward-driven learning.

Investigators say the DRD4 7R allele moderates dopamine signaling, which enhances individuals reactivity to their environment.

People who carry this variant gene, Moyzis said, seem to be more motivated to pursue social, intellectual and physical activities. The variant is also linked to attention-deficit/hyperactivity disorder and addictive and risky behaviors.

While the genetic variant may not directly influence longevity, Moyzis said, it is associated with personality traits that have been shown to be important for living a longer, healthier life.

Its been well documented that the more youre involved with social and physical activities, the more likely youll live longer. It could be as simple as that.

Numerous studies including a number from the 90+ Study have confirmed that being active is important for successful aging, and it may slow the advance of neurodegenerative diseases, such as Alzheimers.

Go here to see the original:
Gene Variant Tied to Active, Longer Life

Bharat Book Presents: China Genetic Engineering Drug Industry Report, 2011-2012
For more information kindly visit on: http://www.bharatbook.com China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs. In recent years, the compound growth rate of genetic engineering drug market in China is as high as 49%, with an average gross margin of more than 80%. However, the technology strength and efficacy of locally produced genetic engineering drugs are relatively weak. In particular, the pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) for injection of CSPC Pharmaceutical Group Limited that approved for marketing in March 2012 is the only homemade long-acting protein product. Still, due to the impetus of huge market capacity as well as a package of preferential policies, many domestic enterprises, including GeneScience Pharmaceuticals, Amoytop and Anhui Anke Biotechnology, are accelerating the industrialized research of long-acting protein drugs. Monoclonal antibody is one of the most promising genetic engineering drugs. As of May 2012, SFDA approved the marketing of a total of 18 monoclonal antibody drugs. Among these drugs, nearly 60% are foreign brands including Roche, Merck and Novartis with the combined sales accounting for three fourths of the Chinese monoclonal antibody drug market. However, with the marketing of monoclonal antibody drugs made by companies such as Shanghai CP Guojian ...

By: Deepa Kamath

The rest is here:
Bharat Book Presents: China Genetic Engineering Drug Industry Report, 2011-2012 - Video

(Fake) FAR CRY 3 : The Movie Trailer - (V2 sound Fix)
The Far Cry Experience : Exclusive Episode 4 is out and 5 as well by now. Far Cry 3 is an open world first-person shooter set on a tropical island unlike any other. This is a place where heavily armed warlords traffic in slaves. Where outsiders are hunted for ransom. And as you embark on desperate quest to rescue your friends, you realize that the only way to escape this darkness... is to embrace it. Far Cry 3 releases December 4th on Xbox 360, PlayStation 3, and PC. For more information go to http://www.farcrygame.com. -- Story of the franchise: Far Cry is a first-person shooter video game developed by Crytek Studios and published by Ubisoft on March 23, 2004, for Microsoft Windows. Far Cry sold 730000 units within four months of release.[1] It received positive reviews upon release. The original game has since spawned a series of sequels and spin-off games and a movie. The game #39;s story follows a former US Army Special Forces operative Jack Carver, who is stranded on a mysterious archipelago. He is searching for a female journalist he was escorting after she went missing when their boat was destroyed by mercenaries. The game includes thematic elements relating to the dangers of weaponizing genetic engineering and the genocide of local islanders as can be seen by the deformed creatures created by a mad scientist named Krieger. The terrain in Far Cry varies greatly. Set on a South Pacific archipelago, the landscape includes beaches, dense rain forests, towering canyons, mines ...

By: John Rambo

See the rest here:
(Fake) FAR CRY 3 : The Movie Trailer - (V2 sound Fix) - Video